DIGESTAR FIBER
Fiber - Psyllium
ICA Registry N ° 9408-MV
Natural Product
INDICATIONS: The active ingredient in DIGESTAR® FIBER improves intestinal transit, has a laxative action, contains large amounts of mucilage that can absorb its weight in water. It is indicated in constipation problems as it facilitates the evacuation of stool.
RECOMMENDED AMOUNT: At the discretion of the veterinarian. Dogs and cats up to 5kg: ½ teaspoon (equivalent to 1.25g). Dogs from 5 to 10 kg: 1 teaspoon (equivalent to 2.5g). Dogs from 10 to 20 kg: 2 teaspoons (equivalent to 5g). Dogs 20 to 30kg: 3 teaspoons (equivalent to 7.5g). The frequency of administration varies according to the individual requirements of each patient.
PRECAUTIONS AND CONTRAINDICATIONS: Do not exceed the recommended dose as it can cause diarrhea, do not use in pregnant or lactating females. Store at a temperature not higher than 30ºC.
Box x 12 Envelopes and Jar x 120g
Icon
Description
With a growing pharmaceutical company and manufacturing industry, a well established healthcare system, and sustainable investment on health research, Colombia continues to be an attractive place for investors and international companies to put their bet on the country.
What positions Colombia as one of the best pharma manufacturers in Latin America is its biodiversity, flexible trade agreements allowing the country to be a great exportation hub and access to innovative technology.
The country’s rich biodiversity offers great opportunity to develop natural products attracting more global companies.
The local production of generic drugs, over-the-counter pharmaceutical products and patent medicines has created a great potential to attract new global markets and multinational companies.
In 2015, pharmaceutical and chemical supplier companies in Colombia exported goods that were worth $525.4 million U.S dollars.
Pharmacy laboratories and pharmaceutical companies in Colombia are well equipped in terms of technology to meet the quality and production standards needed to deliver the best high end pharmacy supplies.
Bogota, the capital of Colombia, holds most of the country’s market with 66% of pharma manufacturers producing pharmaceutical products and where 65% are wholesalers distributors. The city is responsible for 47% of all exportation becoming an important hub to develop chemical synthesis medicines.
The main export destinations are Ecuador, Venezuela, Peru, Panama and the United States.
It is expected for the Colombian pharmaceutical market to grow at a rate of around 7.3 percent and reach a USD 7.1 billion valuation by 2020.
There is no doubt that Colombia offers a great deal for regional production and distribution hubs for pharmaceutical products.
Image
